small molecule

CLARINEX

DESLORATADINE

Loss of exclusivityloss of exclusivity
CompanyOrganonSee this company's full patent-cliff portfolio

Drug detail

Brand nameCLARINEX
Active ingredientDESLORATADINE
Strength0.5MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage formSOLUTION
RouteORAL
ModalitySmall molecule
FDA approvalSeptember 2004
Marketing statusDISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

CLARINEX patent cliff — loss of exclusivity — | CliffBio